GPR30 Promotes the Phenotypic Switching of Vascular Smooth Muscle Cells via Activating the AKT and ERK Pathways

References

• Xu HM, Zhao Y, Zhang XM, Zhu T, Fu WG. Polymorphisms in MMP-9 and TIMP-2 in Chinese patients with varicose veins. J Surg Res. 2011;168(1):e143–148. doi:10.1016/j.jss.2010.11.00221195432
   PubMed Web of Science ®Google Scholar
• Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248–1252. doi:10.1016/j.jvs.2004.09.02715622385
   PubMed Web of Science ®Google Scholar
• Raffetto JD, Qiao X, Beauregard KG, et al. Functional adaptation of venous smooth muscle response to vasoconstriction in proximal, distal, and varix segments of varicose veins. J Vasc Surg. 2010;51(4):962–971. doi:10.1016/j.jvs.2009.11.03720347695
   PubMed Web of Science ®Google Scholar
• Xu Y, Bei Y, Li Y, et al. Phenotypic and functional transformation in smooth muscle cells derived from varicose veins. J Vasc Surg Venous Lymphat Disord. 2017;5(5):723–733. doi:10.1016/j.jvsv.2017.04.00928818228
   PubMedGoogle Scholar
• Wang X, Khalil RA. Matrix metalloproteinases, vascular remodeling, and vascular disease. Adv Pharmacol. 2018;81:241–330.29310800
   PubMedGoogle Scholar
• Naoum JJ, Hunter GC, Woodside KJ, Chen C. Current advances in the pathogenesis of varicose veins. J Surg Res. 2007;141(2):311–316. doi:10.1016/j.jss.2006.08.00717070551
   PubMed Web of Science ®Google Scholar
• Ciardullo AV, Panico S, Bellati C, et al. High endogenous estradiol is associated with increased venous distensibility and clinical evidence of varicose veins in menopausal women. J Vasc Surg. 2000;32(3):544–549. doi:10.1067/mva.2000.10776810957662
   PubMed Web of Science ®Google Scholar
• Vin F, Allaert FA, Levardon M. Influence of estrogens and progesterone on the venous system of the lower limbs in women. J Dermatol Surg Oncol. 1992;18(10):888–892. doi:10.1111/j.1524-4725.1992.tb02922.x1430544
   PubMedGoogle Scholar
• Özcan S, Tezcan O, Kurt T, et al. Serum estradiol/free testosterone ratio can be important predictor for varicose vein recurrence in men. Int Angiol. 2015;34(6):576–581.25791489
   PubMed Web of Science ®Google Scholar
• Kendler M, Makrantonaki E, Kratzsch J, et al. Elevated sex steroid hormones in great saphenous veins in men. J Vasc Surg. 2010;51(3):639–646. doi:10.1016/j.jvs.2009.07.12820045626
   PubMed Web of Science ®Google Scholar
• Huang X, Jin Y, Zhou D, Xu G, Huang J, Shen L. IQGAP1 modulates the proliferation and migration of vascular smooth muscle cells in response to estrogen. Int J Mol Med. 2015;35(5):1460–1466. doi:10.3892/ijmm.2015.213425777140
   PubMed Web of Science ®Google Scholar
• Bastos AN, Alves MM, Monte-Alto-Costa A, et al. α-smooth muscle actin, fibrillin-1, apoptosis and proliferation detection in primary varicose lower limb veins of women. Int Angiol. 2011;30(3):262–271.21617610
   PubMed Web of Science ®Google Scholar
• Montague CR, Hunter MG, Gavrilin MA, et al. Activation of estrogen receptor-alpha reduces aortic smooth muscle differentiation. Circ Res. 2006;99(5):477–484. doi:10.1161/01.RES.0000238376.72592.a216873715
   PubMed Web of Science ®Google Scholar
• Wilkenfeld SR, Lin C, Frigo DE. Communication between genomic and non-genomic signaling events coordinate steroid hormone actions. Steroids. 2018;133:2–7. doi:10.1016/j.steroids.2017.11.00529155216
   PubMed Web of Science ®Google Scholar
• Wang D, Hu L, Zhang G, Zhang L, Chen C. G protein-coupled receptor 30 in tumor development. Endocrine. 2010;38(1):29–37. doi:10.1007/s12020-010-9363-z20960099
   PubMed Web of Science ®Google Scholar
• Petrie WK, Dennis MK, Hu C, et al. G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth. Obstet Gynecol Int. 2013;2013:472720. doi:10.1155/2013/47272024379833
   PubMedGoogle Scholar
• Hua H, Zhang H, Kong Q, Jiang Y. Mechanisms for estrogen receptor expression in human cancer. Exp Hematol Oncol. 2018;7(1):24. doi:10.1186/s40164-018-0116-730250760
   PubMedGoogle Scholar
• Kosaka Y, Quillinan N, Bond C, Traystman R, Hurn P, Herson P. GPER1/GPR30 activation improves neuronal survival following global cerebral ischemia induced by cardiac arrest in mice. Transl Stroke Res. 2012;3(4):500–507. doi:10.1007/s12975-012-0211-823483801
   PubMed Web of Science ®Google Scholar
• Meyer MR, Prossnitz ER, Barton M. The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul Pharmacol. 2011;55(1–3):17–25. doi:10.1016/j.vph.2011.06.00321742056
   PubMed Web of Science ®Google Scholar
• Bergqvist A, Bergqvist D, Fernö M. Estrogen and progesterone receptors in vessel walls Biochemical and Immunochemical Assays . Acta Obstet Gynecol Scand. 1993;72(1):10–16. doi:10.3109/000163493090133418382423
   PubMed Web of Science ®Google Scholar
• Perrot-Applanat M, Cohen-Solal K, Milgrom E, et al. Progesterone receptor expression in human saphenous veins. Circulation. 1992;2975–2983.
   Google Scholar
• Serra R, Gallelli L, Perri P, et al. Estrogen receptors and chronic venous disease. Eur J Vasc Endovasc Surg. 2016;52(1):114–118. doi:10.1016/j.ejvs.2016.04.02027220899
   PubMed Web of Science ®Google Scholar
• Garcia-Honduvilla N, Asunsolo A, Ortega MA, et al. Increase and redistribution of sex hormone receptors in premenopausal women are associated with varicose vein remodelling. Oxid Med Cell Longev. 2018;2018:3974026. doi:10.1155/2018/397402630250632
   PubMed Web of Science ®Google Scholar
• Robertson L, Evans C, Fowkes FG. Epidemiology of chronic venous disease. Phlebology. 2008;23(3):103–111. doi:10.1258/phleb.2007.00706118467617
   PubMed Web of Science ®Google Scholar
• Muto A, Fitzgerald TN, Pimiento JM, et al. Smooth muscle cell signal transduction implications of vascular biology for vascular surgeons. J Vasc Surg. 2007;45(Suppl A):A15–24. doi:10.1016/j.jvs.2007.02.06117544020
   PubMedGoogle Scholar
• Zhang L, Xu Z, Wu Y, Liao J, Zeng F, Shi L. Akt/eNOS and MAPK signaling pathways mediated the phenotypic switching of thoracic aorta vascular smooth muscle cells in aging/hypertensive rats. Physiol Res. 2018;67(4):543–553. doi:10.33549/physiolres.93377929750880
   PubMed Web of Science ®Google Scholar
• Filardo EJ, Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab. 2005;16(8):362–367. doi:10.1016/j.tem.2005.08.00516125968
   PubMed Web of Science ®Google Scholar
• Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402(6764):884–888. doi:10.1038/4726010622253
   PubMed Web of Science ®Google Scholar
• Yang WR, Zhu FW, Zhang JJ, et al. PI3K/Akt activated by GPR30 and Src regulates 17β-estradiol-induced cultured immature boar sertoli cells proliferation. Reprod Sci. 2017;24(1):57–66. doi:10.1177/193371911664969627222231
   PubMed Web of Science ®Google Scholar
• Fujiwara S, Terai Y, Kawaguchi H, et al. GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer. J Ovarian Res. 2012;5(1):35. doi:10.1186/1757-2215-5-3523163984
   PubMed Web of Science ®Google Scholar